New cephalosporins cefotaxime, cefpimizole, BMY 28142, and HR 810 in experimental pneumococcal meningitis in rabbits.
AUTOR(ES)
Täuber, M G
RESUMO
Four new cephalosporins, cefotaxime, cefpimizole (U 63196E), BMY 28142, and HR 810 were evaluated in experimental pneumococcal meningitis. Cefotaxime penetrated only moderately into the cerebrospinal fluid of rabbits with meningitis, whereas cefpimizole, BMY 28142, and HR 810 all exhibited unusually good penetration. The bactericidal activity in infected cerebrospinal fluid was comparable for the four drugs.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=176273Documentos Relacionados
- Rifampin for therapy of experimental pneumococcal meningitis in rabbits.
- Quinolone antibiotics in therapy of experimental pneumococcal meningitis in rabbits.
- Comparison of a new cephalosporin, BMY 28142, with other broad-spectrum beta-lactam antibiotics.
- Influence of body temperature on bacterial growth rates in experimental pneumococcal meningitis in rabbits.
- High-pressure liquid chromatographic assay and pharmacokinetics of HR 810 after intramuscular injection in rabbits.
